135 related articles for article (PubMed ID: 6580660)
1. Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response.
Meltzer HY; Busch DA; Fang VS
Psychiatry Res; 1983 Aug; 9(4):271-83. PubMed ID: 6580660
[TBL] [Abstract][Full Text] [Related]
2. Serum prolactin response to chlorpromazine and psychopathology in schizophrenics: implications for the dopamine hypothesis.
Meltzer HY; Busch D
Psychiatry Res; 1983 Aug; 9(4):285-99. PubMed ID: 6580661
[TBL] [Abstract][Full Text] [Related]
3. Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls.
Meltzer HY; Busch DA; Creese IR; Snyder SH; Fang VS
Psychiatry Res; 1981 Aug; 5(1):95-105. PubMed ID: 6944710
[TBL] [Abstract][Full Text] [Related]
4. Prolactin secretion response to TRH stimulation in acute and chronic schizophrenic patients under neuroleptic treatment.
Cabranes JA; Fuentenebro F; Recio MN; Borque M; Almoguera MI
Int Pharmacopsychiatry; 1982; 17(1):1-7. PubMed ID: 6123489
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: a replication study.
Kolakowska T; Orr M; Gelder M; Heggie M; Wiles D; Franklin M
Br J Psychiatry; 1979 Oct; 135():352-9. PubMed ID: 519119
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
Kolakowska T; Wiles DH; Gelder MG; McNeilly AS
Psychopharmacology (Berl); 1976 Aug; 49(1):101-7. PubMed ID: 8814
[TBL] [Abstract][Full Text] [Related]
7. Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine.
Alfredsson G; Bjerkenstedt L; Edman G; Härnryd C; Oxenstierna G; Sedvall G; Wiesel FA
Acta Psychiatr Scand Suppl; 1984; 311():49-74. PubMed ID: 6199949
[TBL] [Abstract][Full Text] [Related]
8. Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients.
Kolakowska T; Wiles DH; McNeilly AS; Gelder MG
Psychol Med; 1975 May; 5(2):214-6. PubMed ID: 240179
[TBL] [Abstract][Full Text] [Related]
9. Dopamine, serotonin and alpha-adrenergic receptor blocking activities in serum and their relationships to prolactin level in schizophrenic patients receiving long-term chlorpromazine treatment.
Nakahara T; Hirano M; Uchimura H; Saito M; Kim JS; Matsumoto T; Yokoo H; Shimomura M; Mukai A
Psychopharmacology (Berl); 1983; 79(2-3):266-70. PubMed ID: 6133307
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine tests during treatment with neuroleptic drugs: I. Plasma prolactin response to chlorpromazine challenge.
Kolakowska T; Fraser S; Franklin M; Knox J
Psychopharmacology (Berl); 1981; 72(3):283-5. PubMed ID: 6111824
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment.
Wiles DH; Kolakowska T; McNeilly AS; Mandelbrote BM; Gelder MG
Psychol Med; 1976 Aug; 6(3):407-15. PubMed ID: 996201
[TBL] [Abstract][Full Text] [Related]
12. Effect of a drug holiday on plasma chlorpromazine levels in chronic schizophrenic patients.
Hershey LA; Gift T; Atkins RW; Rivera-Calimlim L
Psychopharmacology (Berl); 1981; 73(4):355-8. PubMed ID: 6789357
[TBL] [Abstract][Full Text] [Related]
13. Propranolol in schizophrenia. II. Clinical and biochemical aspects of combining propranolol with chlorpromazine.
Peet M; Middlemiss DN; Yates RA
Br J Psychiatry; 1981 Aug; 139():112-7. PubMed ID: 7030443
[TBL] [Abstract][Full Text] [Related]
14. Effects of trihexyphenidyl on plasma chlorpromazine in young schizophrenics.
Rockland L; Cooper T; Schwartz F; Weber D; Sullivan T
Can J Psychiatry; 1990 Oct; 35(7):604-7. PubMed ID: 2268840
[TBL] [Abstract][Full Text] [Related]
15. Correlation between plasma chlorpromazine and its metabolites and clinical ratings in patients with acute relapse of schizophrenic and paranoid psychosis.
Phillipson OT; McKeown JM; Baker J; Healey AF
Br J Psychiatry; 1977 Aug; 131():172-84. PubMed ID: 912219
[TBL] [Abstract][Full Text] [Related]
16. Serum prolactin levels following intramuscular chlorpromazine: two- and three-hour response as predictors of six-hour response.
Busch DA; Fang VS; Meltzer HY
Psychiatry Res; 1979 Oct; 1(2):153-9. PubMed ID: 45130
[TBL] [Abstract][Full Text] [Related]
17. Effect of chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patients.
Wode-Helgodt B; Eneroth P; Fyrö B; Gullberg B; Sedvall G
Acta Psychiatr Scand; 1977 Oct; 56(4):280-93. PubMed ID: 335789
[TBL] [Abstract][Full Text] [Related]
18. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
Chouinard G; Annable L; Jones BD; Collu R
Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
[TBL] [Abstract][Full Text] [Related]
19. Does a plasma level of chlorpromazine help?
Van Putten T; May PR; Jenden DJ
Psychol Med; 1981 Nov; 11(4):729-34. PubMed ID: 6119719
[TBL] [Abstract][Full Text] [Related]
20. Prediction of response to chlorpromazine treatment in schizophrenics.
Sakurai Y; Nakahara T; Takahashi R
Psychopharmacologia; 1975 Oct; 44(2):195-203. PubMed ID: 1105634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
